Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Bosentan 62.5mg tablets |
BNF code | 0205010U0AAAAAA |
Virtual Therapeutic Moiety | Bosentan |
Date identifier became valid | 27 May 2021 |
Previous product identifier | 407815004 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | tablet |
Unit dose unit of measure | tablet |
Virtual Product Ingredient | |
---|---|
Ingredient | Bosentan monohydrate |
Basis of pharmaceutical strength | Based on Base Substance |
Basis of strength substance identifier | 385559004 |
Strength value numerator | 62.500 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | tablet.oral |
Dose Form | |
Formulation | Oral tablet |
Drug Route | |
Route | Oral |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Bosentan 62.5mg tablets (Accord-UK Ltd) | |
Bosentan 62.5mg tablets (Cipla EU Ltd) | |
Bosentan 62.5mg tablets (Viatris UK Healthcare Ltd) | |
Virtual Medicinal Product Packs | |
Bosentan 62.5mg tablets 56 tablet |
dm+d data retrieved from TRUD: release NHSBSA_10.0.0_20241007000001, imported on 7th October 2024 at 04:53:31.